Geraldine Henwood, President and CEO at Recro Pharma, Inc. (REPH), bought 4,500 shares at $9.56 ($40K) on 2015-06-08, disclosed to the SEC on 2015-06-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.83 | 3,950 | $35K | 86.9% |
| 2 | $9.56 | 550 | $5K | 13.1% |
| Total | $8.92 avg | 4,500 | $40K | 100% |
| Filing → |
| BXRX | BUY | 2021-05-10 | $5K | — | Filing → |
| REPH | SELL | 2020-04-20 | $658K | — | Filing → |
| REPH | SELL | 2019-05-15 | $1.5M | — | Filing → |